Dennis M. Lanfear, President & CEO at Coherus BioSciences, Inc. (CHRS), sold 223,100 shares at $2.02 ($451K) on 2023-11-22, disclosed to the SEC on 2023-11-24.
Open-market sale of $451k CHRS by President & CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| CHRS | SELL | 2019-11-22 | $14.8M | — | Filing → |
| CHRS | SELL | 2019-05-31 | $1.3M | — | Filing → |
| CHRS | SELL | 2018-05-17 | $682K | — | Filing → |